Subjective and physiological effects of oromucosal sprays containing cannabinoids (nabiximols): potentials and limitations for psychosis research.

Current pharmaceutical design

Volumn 18, Issue 32, 2012, Pages 5008-5014

  Schoedel, Kerri A ^a   Harrison, Sarah Jane ^b  

^a SYNEOS HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID;

CANNABIS ADDICTION; DRUG ADMINISTRATION ROUTE; HUMAN; MOUTH MUCOSA; PSYCHOSIS; REVIEW;

CANNABINOIDS; DRUG ADMINISTRATION ROUTES; HUMANS; MARIJUANA ABUSE; MOUTH MUCOSA; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 84875551898     PISSN: None     EISSN: 18734286     Source Type: Journal    
DOI: None     Document Type: Review

References (0)